Sign Up Today and Learn More About Redcliffe Labs Stock
Invest in or calculate the value of your shares in Redcliffe Labs or other pre-IPO companies through EquityZen's platform.
Redcliffe Labs Stock (REDL)
Redcliffe is a diagnostics service provider that offers radiology and pathology services.
About Redcliffe Labs Stock
Founded
2018
Industries
Messaging and Telecommunications, Content and Publishing, Sports
Redcliffe Labs Press Mentions
Stay in the know about the latest news on Redcliffe Labs
3 in 5 women at risk of anaemia in India, says Redcliffe Labs report
business-standard • Mar 06, 2025
Budget 2025: Measures to improve accessibility, affordability are among 3 key expectations to benefit Diagnostics firms
livemint • Jan 22, 2025
LeapFrog Investments Raises $1.15bn to Invest in Healthtech & Fintech Startups Globally
techmoran • Nov 29, 2024
Lunit, AstraZeneca to develop AI-based digital pathology and more briefs
mobihealthnews • Nov 20, 2024
Redcliffe Labs CEO Kandoi on IPO timeline, another funding round, and more
vccircle • Oct 19, 2024
Redcliffe Labs Management
Leadership team at Redcliffe Labs
Co-Founder & Managing Director
Dheeraj Jain
Co-Founder & COO Genomics & Genetic Diagnostics
Ashish Dubey
Join now and verify your accreditation status to gain access to:
- Redcliffe Labs Current Valuation
- Redcliffe Labs Stock Price
- Redcliffe Labs Management
- Available deals in Redcliffe Labs and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Redcliffe Labs Cap Table and Funding History by Share Class and Liquidity Preferences
- Redcliffe Labs Revenue and Financials
- Redcliffe Labs Highlights
- Redcliffe Labs Business Model
- Redcliffe Labs Risk Factors
- Redcliffe Labs Research Report from SACRA Research
Trading Redcliffe Labs Stock
How to invest in Redcliffe Labs stock?
Accredited investors can buy pre-IPO stock in companies like Redcliffe Labs through EquityZen funds. These investments are made available by existing Redcliffe Labs shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Redcliffe Labs stock?
Shareholders can sell their Redcliffe Labs stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
